Equity Capital Markets

Company · CIK 1817713

Janux Therapeutics, Inc.

CIK1817713 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
ListedJANX (Nasdaq)
First annual or quarterly report2021-08-10

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-279196
ShelfEffective
 2024-05-082024-12-053
333-266720
ShelfEffective
 2022-08-092024-02-296
333-256297
IPOFinal prospectus
 2021-05-192021-06-114

Filings

14
FiledFilingRegistrationAccession
2024-12-05424B5Shelf takedown 333-2791960001193125-24-271563
2024-12-03424B5Shelf takedown 333-2791960001193125-24-270017
2024-05-08S-3ASRShelf registered 333-2791960001193125-24-133838
2024-02-29424B5Shelf takedown 333-2667200001193125-24-053696
2024-02-28424B5Shelf takedown 333-2667200001193125-24-048573
2023-07-18424B5Shelf takedown 333-2667200001193125-23-188936
2023-05-09424B5Shelf takedown 333-2667200001193125-23-139520
2022-09-19EFFECTDeclared effective 333-2667209999999995-22-002748
2022-08-09S-3Shelf registered 333-2667200001193125-22-216311
2021-06-11424B4Final prospectus 333-2562970001193125-21-188952
2021-06-10EFFECTDeclared effective 333-2562979999999995-21-002300
2021-06-07S-1/AAmendment 333-2562970001193125-21-183568
2021-05-19S-1Registration filed 333-2562970001193125-21-166730
2021-04-16DRSDraft made public 377-046700000950123-21-004640

All filings of this company · CSV